Memorial Sloan Kettering Cancer Center 4th Annual MSK Symposium on Lymphoma 2019

10 $

+ Include: 37 videos + 35 pdfs, size: 9.74 GB

+ Target Audience: medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma

Description

+ Include: 37 videos + 35 pdfs, size: 9.74 GB

+ Target Audience: medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma

+ Sample video: contact me for sample video

+ Information:

Date & Location

Friday, May 10, 2019, 7:30 AM – Saturday, May 11, 2019, 5:00 PM EST, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties – Bone Marrow Transplant, Hematology, Molecular Biology, Oncology and Hematology, Pathology, Physician Assistant, Radiation Oncology
Overview

This symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biologic and genetic biomarkers into clinical practice and clinical trials.

This symposium is designed for medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

Program Highlights

Networking Cocktail Reception (Friday, May 11, 5:20-6:30 pm) – Participants are invited to join course director, Dr. Anas Younes, and the entire course faculty for a cocktail reception on Friday evening in the lobby of Zuckerman Research Center.

Special Luncheon Events – Participants are invited to attend two special luncheon events, one hosted by the Adult BMT Service and the other hosted by the Myeloma Service. RSVP for the luncheons is required and can be selected during course registration. Please note that space is limited and we do encourage early registration.

  • Adult BMT Luncheon Panel (Friday, May 10, 12:00-1:00 pm)
    Is there a Compelling Role for Hematopoietic Cell Transplantation in Early Relapsed or Refractory Follicular Lymphoma?
    This luncheon will feature updated information on treatment of hematological malignancies during the dawn of the era of immunotherapies in the form of checkpoint inhibitors and chimeric antigen receptor (CAR) T cells. Faculty will review the current standard curative therapy (hematopoietic cell transplantation) and how it has evolved. Participants will have the opportunity to ask questions regarding diagnosis and management, and how to determine treatment standards for the best chance of cure.
  • Myeloma Luncheon Panel (Saturday, May 11, 12:30-1:30 pm)
    Advances in the Treatment and Monitoring of Multiple Myeloma
    This luncheon will provide information on use of CAR-T therapy in myeloma and methods to detect low levels of disease by mass spectrometry. Faculty will provide their perspective on the future of these techniques in multiple myeloma. Participants will have the opportunity to discuss how to incorporate these new approaches into clinical practice and clinical trials.
Objectives
  1. provide up-to-date information on recent molecular diagnostic methods
  2. provide up-to-date information on recent updates to lymphoma pathology classification
  3. provide up-to-date information on recent treatment options for patients with Hodgkin and non-Hodgkin lymphoma

 

+ Topics:

Biology of MCL.mp4
Biology of MCL.pdf
Can a Lymphoma Cell Think.mp4
Can a Lymphoma Cell Think.pdf
Can We Apply DLBCL Genetic Classification to Targeted Sequencing Panels.mp4
Can We Apply DLBCL Genetic Classification to Targeted Sequencing Panels.pdf
CAR T cell Therapy for Lymphoma.mp4
CAR T cell Therapy for Lymphoma.pdf
CAR T cell Therapy for Multiple Myeloma.mp4
CAR T cell Therapy for Multiple Myeloma.pdf
Checkpoint Inhibitors.mp4
Checkpoint Inhibitors.pdf
Clonal Hematopoiesis.mp4
Clonal Hematopoiesis.pdf
Current and Novel Treatment Approaches to FL.mp4
Current and Novel Treatment Approaches to FL.pdf
Frontline Therapy.mp4
Frontline Therapy.pdf
Hematopoietic Cell Transplantation in Early Relapsed or Refractory Follicular Lymphoma- PRO STANCE.mp4
Hematopoietic Cell Transplantation in Early Relapsed or Refractory Follicular Lymphoma- PRO STANCE.pdf
HL in the Elderly.mp4
HL in the Elderly.pdf
Identification of DLBL Subtypes Requiring Novel Therapy.mp4
Identification of DLBL Subtypes Requiring Novel Therapy.pdf
Immune Receptor Signals in T Cell Lymphoma.mp4
Immune Receptor Signals in T Cell Lymphoma.pdf
Intercepting FL with Low Tumor Burden.mp4
Intercepting FL with Low Tumor Burden.pdf
Introduction and Welcoming Remarks.pdf
Introduction to Clinical Diagnostic Genome Sequencing.mp4
Introduction to Clinical Diagnostic Genome Sequencing.pdf
Lymphoma_2019_Brochure.pdf
Management of Newly Diagnose MCL- Are We Ready for Chemo Free Approach.mp4
Management of Newly Diagnose MCL- Are We Ready for Chemo Free Approach.pdf
Marginal Zone Lymphoma.mp4
Marginal Zone Lymphoma.pdf
Mass Spectrometry for the Detection of Monoclonal Immunoglobulins.mp4
Mass Spectrometry for the Detection of Monoclonal Immunoglobulins.pdf
Molecular Biology of Rare Lymphoma Subtypes.mp4
Molecular Biology of Rare Lymphoma Subtypes.pdf
Molecular Classification of DLBCL.mp4
Molecular Classification of DLBCL.pdf
New Insights Into the Biology of Germinal Center Lymphomas.mp4
New Insights Into the Biology of Germinal Center Lymphomas.pdf
Novel Endpoints in Clinical Trials.mp4
Novel Endpoints in Clinical Trials.pdf
Novel Molecular Targets in FL.mp4
Novel Molecular Targets in FL.pdf
Outcome of Relapsed MCL in the Modern Era.mp4
Outcome of Relapsed MCL in the Modern Era.pdf
Panel Discussion I.mp4
Panel Discussion II.mp4
Panel Discussion III.mp4
Panel Discussion IV.mp4
Primary Mediastinal and Grey Zone Lymphoma.mp4
Primary Mediastinal and Grey Zone Lymphoma.pdf
Role of Radiation Therapy.mp4
Role of Radiation Therapy.pdf
State of the Lymphoma at MSK.mp4
State of the Lymphoma at MSK.pdf
Targeting the Epigenome of Follicular Lymphoma.mp4
Targeting the Epigenome of Follicular Lymphoma.pdf
Therapy of Newly Diagnosed Patients.mp4
Therapy of Newly Diagnosed Patients.pdf
Therapy of Relapsed HL.mp4
Therapy of Relapsed HL.pdf
Waldenstrom Macroglobulinemia.mp4
Waldenstrom Macroglobulinemia.pdf
What Can We Learn from Rare FL Variants.mp4
What Can We Learn from Rare FL Variants.pdf
Whole Genome Sequencing in DLBCL and FL.mp4
Whole Genome Sequencing in DLBCL and FL.pdf

Reviews

There are no reviews yet.

Be the first to review “Memorial Sloan Kettering Cancer Center 4th Annual MSK Symposium on Lymphoma 2019”

Your email address will not be published. Required fields are marked *